Back to Trades
van Houte Hans
Chief Financial OfficerCIK 0001817217
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 10
- Companies
- 1
- Active
- 2025–2026
van Houte Hans, Chief Financial Officer, accounts for 9 disclosed filings worth $2.2M, all concentrated in Nurix Therapeutics, Inc. (NRIX), active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $685.9K in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Aug 4 | NRIX Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Sell | $116.0K |
| Jul 30 | NRIX Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Sell | $66.5K |
| May 5 | NRIX Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Sell | $233.3K |
| Apr 30 | NRIX Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Sell | $39.7K |
| Feb 10 | NRIX Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Award | $1.5M |
| Nov 3 | NRIX Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Sell | $78.9K |
| Oct 30 | NRIX Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Sell | $40.1K |
| Aug 1 | NRIX Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Sell | $59.6K |
| Jul 30 | NRIX Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | Sell | $51.7K |
9 filings